Compare PRAX & DJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | DJT |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 4.5B |
| IPO Year | 2020 | N/A |
| Metric | PRAX | DJT |
|---|---|---|
| Price | $286.98 | $13.96 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $373.79 | N/A |
| AVG Volume (30 Days) | 771.9K | ★ 16.5M |
| Earning Date | 11-05-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,463,000.00 | $3,677,900.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12,467.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 364.98 | 9.14 |
| 52 Week Low | $26.70 | $10.18 |
| 52 Week High | $317.72 | $43.46 |
| Indicator | PRAX | DJT |
|---|---|---|
| Relative Strength Index (RSI) | 63.90 | 56.82 |
| Support Level | $285.95 | $12.57 |
| Resistance Level | $317.72 | $15.15 |
| Average True Range (ATR) | 12.78 | 1.08 |
| MACD | -1.09 | 0.14 |
| Stochastic Oscillator | 43.76 | 53.19 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.